Health
A funding dispute with G.O.P. senators may complicate Biden’s efforts on antivirals and tests.
A funding dispute with Republican senators might complicate the Biden administration’s efforts to ensure provides of free antiviral capsules and monoclonal antibody remedies this 12 months to Individuals who check constructive for the coronavirus.
At subject is whether or not the White Home has offered the extent of element desired by Republicans concerning the trillions of {dollars} in Covid reduction spending that Congress beforehand licensed. A bunch of three dozen Republican senators, led by Mitt Romney of Utah, informed the White Home final week that they’d not think about billions in new Covid reduction spending with no extra detailed accounting of how current funds had been spent and whether or not any cash was left over.
“It isn’t but clear why further funding is required,” they wrote in a letter to President Biden on Wednesday.
Administration officers have requested $22.5 billion for added vaccines, oral antivirals and monoclonal antibodies, testing and assist for the worldwide vaccination effort.
Republican senators have steered that the administration ought to divert cash from the $1.9 trillion pandemic regulation to the areas of want, slightly than have Congress spend billions of latest funds.
Jen Psaki, the White Home press secretary, mentioned on Friday that the present provide of monoclonal antibodies will run out by Could and shares of oral antivirals can be depleted by September with out new purchases. “That is an pressing request,” she mentioned.
A breakdown of spending on Covid-related provides like testing, vaccines and coverings offered to Congress by the Biden administration and obtained by The New York Instances indicated that just about all current funds had been spent or dedicated in signed contracts, and that any remaining funds had been allotted. The administration supplied some element on its plans for brand new Covid spending in a letter to Congress on Wednesday.
The funding dispute is taking part in out because the White Home tries to place in place plans that it says are important to the nation’s efforts to return to a semblance of normalcy.
A whole bunch of pharmacies and different well being services have been ready to launch a “check to deal with” program this week permitting folks to stroll in for a coronavirus check and, if the outcomes are constructive, to depart with free antiviral capsules, administration officers mentioned.
Final week, the Division of Protection informed STAT, a medical information outlet, that it might train contract choices to purchase extra of Pfizer’s antiviral remedy, often known as Paxlovid, as soon as funding turned out there.
The White Home additionally mentioned that Individuals who had already obtained a package deal of 4 free at-home coronavirus checks from the federal government would grow to be eligible this week to put a second order on covidtests.gov.
New virus circumstances in the US have plunged in latest weeks, however greater than 1,500 Individuals are nonetheless dying from the virus every day on common.
There are additionally indicators {that a} specific model of the Omicron variant that’s much more contagious than the one which tore via the US this winter is changing into extra prevalent, rising to roughly 8 % of sequenced circumstances in the US by late February. However general circumstances stay on the decline and vaccines look to be equally efficient towards the Omicron subvariant, which doesn’t look like any extra extreme.
Biden administration officers hope to incorporate the $22.5 billion in coronavirus support, alongside humanitarian and navy support for Ukraine, in a sprawling catchall spending package deal that will fund the federal government for the rest of the fiscal 12 months. Congress has till March 11, when funding is about to lapse, to hammer out the small print of a deal.
Health
Why is being scared fun? The science behind fear
Many favorable Halloween activities, such as strolling through a haunted house or watching a horror movie, are filled with elements designed to elicit fear, yet they are still enjoyable pastimes for many.
When it comes to horror movies specifically, several polls have pointed to a fairly even overall split between those who enjoy them and those who would rather do without.
For example, a 2022 survey conducted by Statista found that 64% of adults ages 30 to 44 either liked or loved watching horror movies.
THRIVING WITH ANXIETY: EXPERT TIPS ON EMBRACING THE MENTAL HEALTH CONDITION
So why do some people enjoy participating in scary activities while others do not find the same amusement?
When watching a horror movie, viewers know that what they see while watching can’t actually hurt them — yet the viewing experience can still be a terrifying one.
“When we think about triggers, we all come to our lives with a different story of experiences, and that’s a piece of it, but when we kind of pull the lens out a little bit more and take a look at all of our fears, they kind of fall into one of two buckets when we’re talking about an internal fear,” Dr. Mary Poffenroth, a scientist and fear expert based in Los Angeles and author of “Brave New You,” told Fox News Digital in a phone interview.
“Either fear of not enough or fear of losing control,” she added.
An example of the fear of losing control could be a person experiencing a jump scare, according to Poffenroth, which can be viewed as something that can’t be controlled.
Self-confidence could be another factor that comes into play.
CLICK HERE TO SIGN UP FOR OUR LIFESTYLE NEWSLETTER
“If you’re somebody that maybe is struggling with self-confidence … and [you’re] putting yourself into scary situations or scary movies or haunted houses like that, you may feel like that fear [of] not enough, of not being courageous enough or brave enough or tough enough,” Poffenroth said.
Such feelings that develop inside when a scary element is present start in the brain — which can signal to the body that it’s in danger, even though it may not actually be, according to experts.
“In our brain, we have two almond-shaped structures, one on the left, one on the right, that we’re going to refer to as the amygdala,” said Poffenroth.
“Even though the entire process is a little bit more complicated, in easier terms, it’s the amygdala that is going to be the driver of our fear response, and the amygdala works in an on-off switch, even though there’s a spectrum of intensity.”
“When we overcome any obstacle, we not only feel better about ourselves, but we get those dopamine hits.”
The amygdala can either signal a person is in danger or alert the body that everything is safe.
HALLOWEEN-THEMED BOOKS THAT WILL GIVE YOU A FRIGHT THIS SPOOKY SEASON
“That amygdala can get turned on so easily in our modern world, and it’s super overprotective,” Poffenroth added. “It’s trying to get us to stay in the blanket cave as much as possible and not go out in the world, because the world is big and scary — but that’s not truly living the life that we say that we want.”
For more Lifestyle articles, visit www.foxnews.com/lifestyle
Some find an enjoyable adrenaline rush when it comes to activities that scare them. They can feel a strong sense of pride after overcoming an obstacle that stood in their way.
“When we start to do scary stuff, and we overcome that kind of level or barrier, and then we level up, if you will — then we become more confident that we can handle bigger and bolder types of opportunities,” Poffenroth said.
For those who find enjoyment in accomplishing scary feats, it could also simply be their personality that makes them this way, causing them to always want to step out of their comfort zone and push their limits.
“Sometimes that’s just a personality trait,” Poffenroth said. “For me, I really enjoy pushing the boundaries of what I think I can do, what society says I’m allowed to do, and that’s just something I enjoy.”
“When we overcome any obstacle, we not only feel better about ourselves, but we get those dopamine hits, and that reward center gets fired up,” Poffenroth continued.
“If we found it a positive experience, then we’ll want to do it more.”
Health
Breast cancer patient says new type of chemo saved her life: ‘I am thriving’
Just as no two cancers are the same, treatment isn’t one-size-fits-all — and for one Arizona mother and teacher, personalized chemotherapy became the path to survival.
Tammy Morrow, 55, had been healthy for decades when, after seeing a doctor for what she thought was a stomach bug in December 2023, she was blindsided by a diagnosis of stage 4 metastatic breast cancer.
The cancer had spread to her bones, lymph nodes, liver and other areas, she told Fox News Digital. It became evident fairly quickly that her disease was beyond the scope of traditional treatments.
CHEMOTHERAPY DRUG COULD HAVE A SERIOUS AND SURPRISING SIDE EFFECT, STUDY FINDS
“I received one round of traditional chemo in the hospital,” said Morrow, who lives in Phoenix, Arizona. “After just the one treatment, all of my hair fell out within just eight days.”
“The rapid hair loss demonstrates the systemic nature and toxicity of traditional chemo,” she added.
Morrow’s oncologist told her that she likely only had months to live, but she was determined to find another alternative.
Through her research, she found Envita Medical Center in Scottsdale, which offers a novel cancer treatment called Genetically Targeted Fractionated Chemotherapy (GTFC).
HALF OF CANCER DEATHS COULD HAVE BEEN PREVENTED THROUGH LIFESTYLE CHANGES, SAYS AMERICAN CANCER SOCIETY REPORT
“When I arrived at Envita, I was not taking in food orally, and for almost three months, I had to receive all of my nutrition from a catheter delivered directly into my veins,” Morrow said.
She began receiving GTFC treatments, which she credits as “essential to survival.”
“In just 21 weeks, my diagnosis changed from terminal to normal.”
“I am persuaded that I would not be alive today if I had not received care at Envita,” Morrow told Fox News Digital.
“Now, I am thriving.”
BREAST CANCER SIGNS, SYMPTOMS TO LOOK OUT FOR, PLUS WHEN TO SCHEDULE ROUTINE SCREENING
Morrow’s last several blood tests have shown no evidence of disease, and her most recent PET scan in May confirmed that she is cancer-free.
“In just 21 weeks, my diagnosis changed from terminal to normal,” she said.
Making it personal
Genetically targeted fractionated chemotherapy (GTFC) is a targeted approach to cancer treatment that personalizes chemotherapy based on a patient’s genetic makeup and specific tumor biology, according to Dr. John Oertle, chief medical director at Envita Medical Centers.
“This method also enhances the tumor’s ability to absorb the chemotherapy, allowing us to use reduced dosages while maintaining effectiveness,” Oertle, who specializes in “individualized, outcome-based care models for chronic disease and integrative oncology,” told Fox News Digital.
GTFC is designed to deliver medicine with more precision while having fewer side effects, he noted.
BREAST CANCER DIAGNOSES SPIKING AMONG WOMEN UNDER 50, NEW REPORT REVEALS
“Conventional chemotherapy targets all rapidly dividing cells, both cancerous and healthy, using high doses, which often leads to widespread side effects,” Oertle said.
“Additionally, we have found that 90% of patients on conventional chemotherapy are dealing with cancer that has already become resistant to it.”
GTFC is designed to specifically target cancer cells with genetic mutations, he said, so that more chemo gets into the tumor.
“While only 5% to 7% of conventional chemotherapy administered through an IV typically reaches the tumor, GTFC significantly improves this uptake,” Oertle said.
“As a result, we can reduce the overall dosage and administer treatment more frequently.”
“Not only are these specific treatments resulting in better outcomes, they are less harmful as well.”
Fox News medical contributor Dr. Nicole Saphier, who is not associated with Envita, referred to GTFC as “the future of cancer treatment.”
“Historically, we depended on traditional chemotherapy to kill cancer cells,” she told Fox News Digital.
“Unfortunately, traditional chemotherapy isn’t very specific, so while it killed cancer cells, it also killed healthy cells.”
Because of this limitation, traditional chemo can have “severe” short-term and long-term side effects, Saphier confirmed.
“GTFC is a targeted therapy, which is a type of cancer treatment that’s designed to attack cancer cells while leaving healthy cells alone,” she went on.
“Not only are these specific treatments resulting in better outcomes, they are less harmful as well.”
THESE 17 CANCER TYPES ARE MORE COMMON IN GEN X AND MILLENNIALS, AS STUDY NOTES ‘ALARMING TREND’
While there are some possible side effects with GTFC, they are “significantly fewer” than with traditional chemo, Oertle said.
“Many patients are even able to maintain their hair,” he added.
In Morrow’s case, she said her side effects were “minimal,” even after receiving GTFC chemo treatments once or twice every week for 21 weeks.
Her main side effects were weakness and digestive issues for a day or two after the treatment.
NOVEL CANCER TREATMENT OFFERS NEW HOPE WHEN CHEMO AND RADIATION FAIL: ‘BIG CHANGE IN PEOPLE’S LIVES’
“I was even able to work full-time during my treatment,” she said. “On a couple of occasions, I virtually attended work meetings while receiving the chemo treatments.”
Who can get GTFC?
In addition to breast cancer, GTFC can be an option for any type of cancer that needs systemic therapy, according to Oertle.
“For early-stage cancers, we utilize advanced blood tests to ensure that the disease has not spread,” he said.
“If the cancer remains localized, we offer other precision-based, less invasive treatments that may eliminate the need for GTFC. However, for cancers that have spread beyond the initial tumor, GTFC may be an effective treatment option.”
“Most people simply cannot afford to pay for this type of medical care.”
There are some barriers to receiving this type of chemo, however.
“It is very difficult to receive this care because no insurance company in America will cover the advanced and targeted integrated care Envita offers,” Morrow told Fox News Digital.
“Even though the chemotherapy drugs I received at Envita are a part of the normal medical protocol, because the method of delivering these chemotherapy drugs is not normal, my insurance company refused to cover any of it.”
Morrow paid nearly $250,000 out of pocket for her chemo treatments.
“Most people simply cannot afford to pay for this type of medical care — and I could not have afforded it, either,” she said.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
To cover the cost, Morrow’s two sons started a GoFundMe and raised almost $120,000, and Morrow and her husband took out a second mortgage to cover the rest.
“I would encourage people to not let the cost prevent them from seeking out this innovative and life-saving approach to cancer care,” Morrow urged.
“I pray that one day, I will have the money to help others receive care at Envita. In the meantime, my husband and I have two guest bedrooms waiting to be filled by out-of-town patients.”
Envita includes the below disclaimer on its website.
For more Health articles, visit www.foxnews.com/health
“Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient’s case is unique. Please consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or achieves these results. Treatments used in this case may not all be FDA-approved for the treatment of this condition.”
Fox News Digital reached out to the FDA requesting comment.
Health
Heart attack and stroke risk may rise after COVID infection, study finds
A prior COVID infection could make you more susceptible to heart attack, stroke or death, according to a new study from Cleveland Clinic and the University of Southern California.
The risk of a major cardiac event doubled for the three-year period following a positive COVID test, researchers found — even for those with no history of heart disease.
The researchers analyzed data from 10,005 people 50 and older who had COVID and 217,730 who did not contract the virus, pulled from UK Biobank between February and December 2020.
MYOCARDITIS IN YOUNG MALES AFTER COVID VACCINE: NEW STUDY SUGGESTS WHAT MAY CAUSE THE RARE HEART CONDITION
The study, which was funded by the National Institutes of Health, was published in the journal Arteriosclerosis, Thrombosis, and Vascular Biology.
“These studies add to the growing body of data showing that COVID-19 infection can enhance risk for experiencing adverse cardiac events over time,” co-senior study author Stanley Hazen, MD, PhD, chair of cardiovascular and metabolic sciences in Cleveland Clinic’s Lerner Research Institute and co-section head of preventive cardiology, told Fox News Digital.
The researchers were surprised to find that the increased risk remained the same over the three-year period.
COVID INFECTED PATIENTS AT RISK FOR 20 TYPES OF HEART AND VASCULAR DISEASE: STUDY
“The twofold increased risk observed in year one following infection was also seen in year two and even year three,” Hazen noted.
“This was seen in all subjects, independent of age, sex or risk factors for cardiac disease.”
Those who had more adverse symptoms experienced a slightly higher risk than those with milder symptoms.
“Specifically, subjects who had severe COVID-19 infection and required hospitalization were at even higher risk of experiencing a major adverse cardiac event (MACE=myocardial infarction, stroke or death) over the ensuing three years of follow-up,” Hazen said.
Blood type also appeared to impact the risk, the study found.
People with a blood type other than O — such as A, B or AB — had double the risk of a major cardiac event than those with an O blood type.
“This study confirms what many of us have seen anecdotally over the past five years.”
Those with O blood have also been shown to have a higher likelihood of getting a COVID infection.
“Given our collective observations and that 60% of the world’s population have these non-O blood types, our study raises important questions about whether more aggressive cardiovascular risk reduction efforts should be considered, possibly by taking into consideration an individual’s genetic makeup,” Hazen said in a press release.
Dr. Bradley Serwer, a cardiologist and chief medical officer at VitalSolution, a Cincinnati, Ohio-based company that offers cardiovascular and anesthesiology services to hospitals nationwide, was not involved in the research but commented on the “interesting” findings.
“This study confirms what many of us have seen anecdotally over the past five years,” he told Fox News Digital.
“Since the outbreak began, we have seen cardiac complications to include inflammation of the heart, a propensity to form blood clots and an increase in abnormal heart rhythms, particularly atrial fibrillation.”
“The lead author, Dr. Hazen, has some fascinating theories that I assume will be tested in the future.”
Reducing the risk
Based on these findings, Hazen recommends that medical providers consider COVID-19 as a risk factor for heart disease.
“Heart disease is the number one killer worldwide,” he noted.
“With over a billion individuals worldwide having experienced COVID-19 thus far, these studies argue that this is not a small problem — and I hope this serves as a reminder to address global preventive cardiovascular risk-reducing efforts.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Among those efforts are monitoring cholesterol levels and blood pressure, adopting an exercise program, and being more mindful of diet.
“Please let this study be a reminder — if you are 50 or older and have experienced COVID, ask if you can do anything further to reduce your cardiac risk,” Hazen advised.
“Also, make sure to stay current with your COVID-19 vaccinations and boosters.”
More research needed, experts agree
The study did have some limitations, experts acknowledged.
“These findings signal the need for further investigation,” Hazen said.
For more Health articles, visit www.foxnews.com/health
“A better understanding of what COVID-19 does at the molecular level may potentially teach us about pathways linked to cardiovascular disease risk.”
Serwer agreed, adding, “This study shows an association, but does not prove causality.”
-
Technology1 week ago
Charter will offer Peacock for free with some cable subscriptions next year
-
World1 week ago
Ukrainian stronghold Vuhledar falls to Russian offensive after two years of bombardment
-
World1 week ago
WikiLeaks’ Julian Assange says he pleaded ‘guilty to journalism’ in order to be freed
-
Technology1 week ago
Beware of fraudsters posing as government officials trying to steal your cash
-
Health6 days ago
Health, happiness and helping others are vital parts of free and responsible society, Founding Fathers taught
-
Virginia1 week ago
Status for Daniels and Green still uncertain for this week against Virginia Tech; Reuben done for season
-
Sports7 days ago
Freddie Freeman says his ankle sprain is worst injury he's ever tried to play through
-
News6 days ago
Lebanon says 50 medics killed in past three days as Israel extends its bombardment